Sign up to save your podcasts
Or
Share Atsena’s XLRS Gene Therapy Shows Efficacy in Phase 1/2 Clinical Trial
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Atsena’s XLRS Gene Therapy Shows Efficacy in Phase 1/2 Clinical Trial
The XLRS gene therapy was well tolerated and resolved damaging schisis cavities in patients receiving the lowest dose.
View all episodes
By Foundation Fighting Blindness
4.9
2424 ratings
The XLRS gene therapy was well tolerated and resolved damaging schisis cavities in patients receiving the lowest dose.
More shows like Foundation Fighting Blindness
View all
The Ramsey Show
38,997 Listeners
Real Time with Bill Maher
16,345 Listeners
Making Sense with Sam Harris
26,397 Listeners
Pivot
9,477 Listeners
The Jordan Harbinger Show
12,029 Listeners
Suze Orman's Women & Money (And Everyone Smart Enough To Listen)
4,448 Listeners
Hacks On Tap
8,054 Listeners
All-In with Chamath, Jason, Sacks Friedberg
9,810 Listeners
Call Me Back - with Dan Senor
3,251 Listeners
Huberman Lab
29,128 Listeners
On with Kara Swisher
3,426 Listeners
What Now? with Trevor Noah
4,215 Listeners
Letters from an American
5,748 Listeners
The Blind Life Podcast
20 Listeners
The Last Invention
297 Listeners